Bo Baldetorp
101 – 110 of 149
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 1996
-
Mark
Flow cytometry analysis of malignant tumors of the head and neck--differences between two methods in the recognition of aneuploidy
- Contribution to journal › Article
-
Mark
Methodological aspects of flow cytometry DNA analysis in endometrial carcinoma, with special reference to sampling and reproducibility
- Contribution to journal › Article
- 1995
-
Mark
Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation
- Contribution to journal › Article
-
Mark
The prognostic information of DNA ploidy and S-phase fraction may vary with histologic grade in endometrial carcinoma
- Contribution to journal › Article
-
Mark
Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates
- Contribution to journal › Article
- 1994
-
Mark
Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group
- Contribution to journal › Article
-
Mark
Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis?
- Contribution to journal › Article
-
Mark
Abnormal DNA synthesis in polyamine deficient cells revealed by bromodeoxyuridine-flow cytometry technique
- Contribution to journal › Article
-
Mark
ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer
- Contribution to journal › Article
-
Mark
Inter-institutional reproducibility of flow cytometric DNA-analysis in breast carcinomas
- Contribution to journal › Article
